[Indication of pyrifer treatment of neurodermatitis].
D001688:Biological Products / Q000627:therapeutic use*; D006801:Humans; D008070:Lipopolysaccharides; D009450:Neurodermatitis / Q000628:therapy*
D001688:Biological Products; D008070:Lipopolysaccharides; C061966:Pyrifer
BIOLOGICAL PRODUCTS/therapeutic use; NEURODERMATITIS/therapy
Zur Indikation der Pyriferbehandlung bei Neurodermitis.